$SYRS Syros Pharmaceuticals, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Syros Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Syros Pharmaceuticals, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Syros Pharmaceuticals, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| AISLING CAPITAL III LP | 10% Owner | 508,565 | 5,553,530 | Jul 06 2016 | |||
| AKKARAJU SRINIVAS | Director | 1,899,616 | 20,743,807 | Dec 11 2020 | |||
| Alles Mark J | Director | 10,000 | 109,200 | Jun 11 2020 | |||
| Arch Venture Fund VII LP | 10% Owner | 4,302,051 | 46,978,397 | Jul 17 2019 | |||
| Bancel Stephane | Director | 47,980 | 523,942 | Sep 19 2016 | |||
| BONNEY MICHAEL W | Director | 0 | 0 | Jun 15 2018 | |||
| DeSimone Colleen Elizabeth | Principal Accounting Officer | 550 | 6,006 | Oct 23 2017 | |||
| Eckhardt Sue Gail | Director | 0 | 0 | Sep 09 2020 | |||
| Fanucci Marsha | Director | 0 | 0 | Jun 11 2020 | |||
| Ferra Joseph J Jr | Chief Financial Officer | 0 | 0 | Feb 19 2021 | |||
| Flagship Ventures Fund IV, L.P. | 10% Owner | 2,378,663 | 25,975,000 | Aug 21 2017 | |||
| Flynn James E | 10% Owner | 1,186,654 | 12,958,262 | Jul 06 2016 | |||
| Kuvalanka Kyle D. | Chief Operating Officer | 0 | 0 | Feb 13 2017 | |||
| Nashat Amir | Director | 1,164,486 | 12,716,187 | Jun 11 2020 | |||
| NELSEN ROBERT | Director | 479,999 | 5,241,589 | Jun 12 2017 | |||
| Olson Eric R | Chief Scientific Officer | 3,628 | 39,618 | Mar 17 2021 | |||
| Patel Sanj K | Director | 0 | 0 | Jun 12 2017 | |||
| Polaris Management Co. VII, L.L.C. | 10% Owner | 1,164,486 | 12,716,187 | Jul 07 2016 | |||
| Quirk Gerald E | Chief Legal Officer | 0 | 0 | Feb 21 2018 | |||
| Redmile Group, LLC | 10% Owner | 84,760 | 925,579 | Jul 07 2016 | |||
| Roth David | Chief Medical Officer | 0 | 0 | Feb 19 2021 | |||
| SATO VICKI L | Director | 0 | 0 | Jun 12 2019 | |||
| SHARP PHILIP A | Director | 146,666 | 1,601,593 | Jun 11 2020 | |||
| Shaw Alice Tsang | Director | 0 | 0 | Jun 12 2019 | |||
| Simonian Nancy A | President & CEO | 544,450 | 5,945,394 | Feb 19 2021 | |||
| Springhorn Jeremy P. | Chief Business Officer | 15,000 | 163,800 | Feb 19 2021 | |||
| WIRTH PETER | Director | 0 | 0 | Jun 11 2020 | |||
| WuXi Healthcare Ventures II, L.P. | 10% Owner | 423,805 | 4,627,951 | Jul 06 2016 | |||
| WuXi PharmTech Healthcare Fund I L.P. | 10% Owner | 133,333 | 1,455,996 | Jul 07 2016 | |||
| Young Richard A | Director | 321,711 | 3,513,084 | Feb 18 2021 |